$11.99
-0.04-0.33%
At close: -
$12.05
0.060.50%
After Hours: 4:00 PM EDT
Comments
Loading...
Evolus Insider Trading Activity | NASDAQ:EOLS | Benzinga
Track the latest Evolus insider trading activity. Stay informed on recent buys, sells, and market impact for Evolus stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Evolus Inc Insiders Doing?
At Evolus Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 163.95K shares worth $2.16M, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On March 20, 2025, Tomoko Yamagishi-Dressler, the company's CHIEF MARKETING OFFICER sold 4.54K shares for $13.26 each.
- On March 28, 2025, David Moatazedi, the company's SEE REMARKS sold 6.25K shares for $12.4 each.
- On March 20, 2025, Sandra Beaver, the company's CHIEF FINANCIAL OFFICER sold 9K shares for $13.26 each.
Ownership Statistics for Evolus Inc
Shares Outstanding
63.587M
Insider Shares Owned
2.266M
Insider Percentage Owned
3.59%
Institutional Shares Held
22.499M
Institutional Percentage Held
35.4%
| Mar 28, 2025 | David Moatazedi | SEE REMARKS | -6.25K | $12.40 | -$77.51K | SELL | -1.21% | 508.62K | Mar 27 | View |
| Mar 20, 2025 | Rui Avelar | SEE REMARKS | -27.90K | $13.26 | -$369.87K | SELL | -7.15% | 362.47K | Mar 18 | View |
| Mar 20, 2025 | Sandra Beaver | CHIEF FINANCIAL OFFICER | -9.00K | $13.26 | -$119.24K | SELL | -4.93% | 173.58K | Mar 18 | View |
| Mar 20, 2025 | Tomoko Yamagishi-Dressler | CHIEF MARKETING OFFICER | -4.54K | $13.26 | -$60.12K | SELL | -4.53% | 95.67K | Mar 18 | View |
| Mar 20, 2025 | David Moatazedi | SEE REMARKS | -103.38K | $13.26 | -$1.37M | SELL | -16.72% | 514.87K | Mar 18 | View |
| Mar 14, 2025 | Karah Parschauer | DIRECTOR | -12.89K | $12.99 | -$167.47K | SELL | -28.59% | 32.18K | Mar 12 | View |
| Dec 26, 2024 | Rui Avelar | SEE REMARKS | -2.25K | $10.85 | -$24.44K | SELL | -0.61% | 366.60K | Dec 23 | View |
| Dec 26, 2024 | Sandra Beaver | CHIEF FINANCIAL OFFICER | -1.59K | $10.85 | -$17.21K | SELL | -1.07% | 146.92K | Dec 23 | View |
| Dec 26, 2024 | David Moatazedi | SEE REMARKS | -10.50K | $10.85 | -$113.97K | SELL | -1.97% | 522.85K | Dec 23 | View |
| Sep 06, 2024 | Sandra Beaver | CHIEF FINANCIAL OFFICER | -3.28K | $14.98 | -$49.07K | SELL | -2.16% | 148.50K | Sep 06 | View |
| Sep 04, 2024 | Tomoko Yamagishi-Dressler | CHIEF MARKETING OFFICER | -5.63K | $15.85 | -$89.25K | SELL | -6.40% | 82.38K | Aug 30 | View |
| Jun 06, 2024 | David Moatazedi | SEE REMARKS | -140.21K | $9.58 | -$3.88M | SELL | -20.82% | 533.35K | Jun 04 - Jun 06 | View |
| Jun 05, 2024 | Vikram Malik | DIRECTOR | -7.50K | $12.96 | -$97.20K | SELL | -2.95% | 246.51K | Jun 03 | View |
| May 15, 2024 | David N Gill | DIRECTOR | -10.36K | $12.64 | -$131.01K | SELL | -23.38% | 33.96K | May 13 - May 14 | View |
| May 15, 2024 | Vikram Malik | DIRECTOR | -28.00K | $12.93 | -$362.01K | SELL | -9.93% | 254.01K | May 13 | View |
| May 14, 2024 | David Moatazedi | SEE REMARKS | -16.05K | $12.72 | -$204.13K | SELL | -2.33% | 673.56K | May 10 | View |
| May 14, 2024 | Rui Avelar | SEE REMARKS | -3.44K | $12.72 | -$43.76K | SELL | -0.92% | 368.85K | May 10 | View |
| May 14, 2024 | Sandra Beaver | CHIEF FINANCIAL OFFICER | -2.42K | $12.72 | -$30.81K | SELL | -1.57% | 151.78K | May 10 | View |
| Mar 29, 2024 | David Moatazedi | SEE REMARKS | -6.24K | $13.86 | -$86.43K | SELL | -0.90% | 689.61K | Mar 27 | View |
| Mar 21, 2024 | Rui Avelar | SEE REMARKS | -27.60K | $13.92 | -$384.35K | SELL | -6.90% | 372.29K | Mar 19 | View |
| Mar 21, 2024 | Sandra Beaver | CHIEF FINANCIAL OFFICER | -5.67K | $13.92 | -$78.98K | SELL | -3.55% | 154.20K | Mar 19 | View |
| Mar 21, 2024 | David Moatazedi | SEE REMARKS | -96.57K | $13.92 | -$1.34M | SELL | -12.19% | 695.85K | Mar 19 | View |
| Feb 23, 2024 | David Moatazedi | SEE REMARKS | 53.50K | $13.08 | -$100.80K | GRANT | 7.24% | 792.42K | Feb 21 - Feb 22 | View |
| Feb 23, 2024 | Rui Avelar | SEE REMARKS | 11.29K | $13.08 | -$23.82K | GRANT | 2.91% | 399.89K | Feb 21 - Feb 22 | View |
| Feb 23, 2024 | Sandra Beaver | CHIEF FINANCIAL OFFICER | 11.29K | $13.08 | -$23.82K | GRANT | 7.60% | 159.87K | Feb 21 - Feb 22 | View |
| Feb 02, 2024 | Karah Parschauer | DIRECTOR | -11.93K | $13.14 | -$156.73K | SELL | -27.63% | 31.24K | Jan 30 | View |
| Dec 08, 2023 | David Moatazedi | SEE REMARKS | -82.65K | $9.95 | -$822.40K | SELL | -12.04% | 603.94K | Dec 06 - Dec 08 | View |
| Oct 18, 2023 | Medytox Inc | — | -1.69M | $7.50 | -$12.68M | SELL | -33.33% | 3.38M | Oct 16 | View |
| Sep 08, 2023 | Sandra Beaver | CHIEF FINANCIAL OFFICER | -3.18K | $9.70 | -$30.83K | SELL | -2.73% | 113.37K | Sep 06 | View |
| Aug 16, 2023 | Rui Avelar | SEE REMARKS | 17.46K | $10.27 | -$22.71K | GRANT | 5.20% | 353.39K | Aug 14 - Aug 16 | View |
| Aug 16, 2023 | Sandra Beaver | CHIEF FINANCIAL OFFICER | 17.46K | $10.27 | -$22.71K | GRANT | 17.62% | 116.55K | Aug 14 - Aug 16 | View |
| Aug 16, 2023 | David Moatazedi | SEE REMARKS | 77.03K | $10.27 | -$151.77K | GRANT | 12.64% | 686.59K | Aug 14 - Aug 16 | View |
| Aug 15, 2023 | Vikram Malik | DIRECTOR | 197.97K | $7.41 | $1.30M | BUY | 255.16% | 275.55K | Aug 11 - Aug 15 | View |
| Mar 29, 2023 | David Moatazedi | SEE REMARKS | -6.11K | $8.47 | -$51.75K | SELL | -0.99% | 609.57K | Mar 27 | View |
| Mar 16, 2023 | David Moatazedi | SEE REMARKS | -64.21K | $8.47 | -$543.80K | SELL | -9.44% | 615.68K | Mar 14 | View |
| Mar 16, 2023 | Rui Avelar | SEE REMARKS | -14.91K | $8.47 | -$126.24K | SELL | -4.25% | 335.93K | Mar 14 | View |
| Feb 22, 2023 | Alphaeon LLC | — | -1.85M | $8.40 | -$15.54M | SELL | -30.50% | 4.21M | Feb 17 | View |
| Feb 08, 2023 | Medytox Inc | 10% OWNER | -2.19M | $8.50 | -$18.59M | SELL | -30.13% | 5.07M | Feb 07 | View |
| Feb 06, 2023 | Medytox Inc | 10% OWNER | 0.00 | $11.04 | -$116.05 | p / s | 0.00% | 7.26M | Aug 12 - Jan 20 | View |
| Oct 07, 2022 | Medytox Inc | 10% OWNER | -38.30K | $8.99 | -$344.42K | SELL | -0.52% | 7.26M | Oct 06 | View |
| Oct 06, 2022 | Medytox Inc | 10% OWNER | -6.85K | $8.95 | -$61.29K | SELL | -0.09% | 7.30M | Oct 05 | View |
| Sep 16, 2022 | Medytox Inc | 10% OWNER | -97.00K | $10.29 | -$997.78K | SELL | -1.31% | 7.30M | Sep 14 - Sep 15 | View |
| Sep 13, 2022 | Robert Hayman | DIRECTOR | 10.00K | $10.39 | $103.94K | BUY | 25.07% | 49.88K | Sep 09 - Sep 12 | View |
| Sep 12, 2022 | Medytox Inc | 10% OWNER | -36.00K | $10.47 | -$376.89K | SELL | -0.48% | 7.40M | Sep 08 - Sep 09 | View |
| Sep 09, 2022 | Robert Hayman | DIRECTOR | 4.97K | $10.05 | $49.92K | BUY | 14.24% | 39.85K | Sep 07 | View |
| Sep 08, 2022 | Simone Blank | DIRECTOR | 20.00K | $9.24 | $184.84K | BUY | 4.97% | 422.46K | Sep 06 | View |
| Sep 06, 2022 | Peter Farrell | DIRECTOR | 10.00K | $9.10 | $91.05K | BUY | 28.67% | 44.88K | Sep 06 | View |
| Aug 03, 2022 | Medytox Inc | 10% OWNER | -26.00K | $13.28 | -$345.36K | SELL | -0.35% | 7.44M | Aug 01 | View |
| May 18, 2022 | David Moatazedi | SEE REMARKS | -55.32K | $13.64 | -$754.31K | SELL | -10.11% | 491.96K | May 16 | View |
| May 18, 2022 | Lauren Silvernail | SEE REMARKS | -68.20K | $12.78 | -$871.38K | SELL | -32.51% | 141.57K | May 17 - May 18 | View |
| May 17, 2022 | David N Gill | DIRECTOR | -10.31K | $13.35 | -$137.66K | SELL | -25.86% | 29.57K | May 13 - May 16 | View |
| Mar 30, 2022 | David Moatazedi | SEE REMARKS | -6.10K | $11.62 | -$70.93K | SELL | -1.10% | 547.28K | Mar 28 | View |
| Mar 10, 2022 | Crystal Muilenburg | CHIEF MARKETING OFFICER | -6.50K | $9.73 | -$63.17K | SELL | -4.61% | 134.25K | Mar 08 | View |
| Mar 10, 2022 | David Moatazedi | SEE REMARKS | -37.97K | $9.73 | -$369.29K | SELL | -6.42% | 553.39K | Mar 08 | View |
| Mar 10, 2022 | Rui Avelar | SEE REMARKS | -10.19K | $9.73 | -$99.12K | SELL | -3.87% | 253.19K | Mar 08 | View |
| Mar 10, 2022 | Lauren Silvernail | SEE REMARKS | -10.19K | $9.73 | -$99.12K | SELL | -4.63% | 209.78K | Mar 08 | View |
| Sep 07, 2021 | Alphaeon LLC | — | -2.60M | $9.50 | -$24.68M | SELL | -29.99% | 6.06M | Sep 02 | View |
| Aug 31, 2021 | Medytox Inc | 10% OWNER | 51.00K | $10.93 | $557.57K | BUY | 0.69% | 7.46M | Aug 27 | View |
| Aug 27, 2021 | Medytox Inc | 10% OWNER | 110.00K | $11.06 | $1.22M | BUY | 1.51% | 7.41M | Aug 25 - Aug 26 | View |
| Aug 25, 2021 | Vikram Malik | DIRECTOR | -26.08K | $11.00 | -$286.72K | SELL | -2.23% | 1.14M | Aug 23 | View |
| Aug 25, 2021 | Medytox Inc | 10% OWNER | 142.00K | $11.10 | $1.58M | BUY | 1.98% | 7.30M | Aug 23 - Aug 24 | View |
| Aug 23, 2021 | Medytox Inc | 10% OWNER | 103.00K | $10.53 | $1.08M | BUY | 1.46% | 7.16M | Aug 19 - Aug 20 | View |
| Aug 20, 2021 | Vikram Malik | DIRECTOR | -61.84K | $10.59 | -$654.87K | SELL | -5.02% | 1.17M | Aug 19 - Aug 20 | View |
| Aug 19, 2021 | Vikram Malik | DIRECTOR | -67.08K | $10.20 | -$684.56K | SELL | -5.17% | 1.23M | Aug 17 - Aug 18 | View |
| Aug 19, 2021 | Medytox Inc | 10% OWNER | 115.00K | $10.63 | $1.22M | BUY | 1.66% | 7.06M | Aug 17 - Aug 18 | View |
| Aug 17, 2021 | David Moatazedi | SEE REMARKS | -70.44K | $11.13 | -$783.81K | SELL | -15.74% | 377.07K | Aug 13 - Aug 16 | View |
| Aug 17, 2021 | Medytox Inc | 10% OWNER | 114.71K | $11.18 | $1.28M | BUY | 1.68% | 6.94M | Aug 13 - Aug 16 | View |
| Aug 13, 2021 | Medytox Inc | 10% OWNER | 65.29K | $10.87 | $709.45K | BUY | 0.97% | 6.83M | Aug 11 - Aug 12 | View |
| Aug 12, 2021 | Lauren Silvernail | SEE REMARKS | 14.29K | $11.18 | $159.77K | s | 7.91% | 194.98K | Aug 10 | View |
| Aug 12, 2021 | Rui Avelar | SEE REMARKS | -14.29K | $11.18 | -$159.79K | SELL | -6.38% | 209.81K | Aug 10 | View |
| Aug 12, 2021 | Crystal Muilenburg | CHIEF MARKETING OFFICER | 5.36K | $11.18 | $59.94K | s | 5.58% | 101.47K | Aug 10 | View |
| Aug 12, 2021 | David Moatazedi | SEE REMARKS | 41.76K | $11.18 | $466.84K | s | 8.54% | 531.04K | Aug 10 | View |
| Jan 26, 2021 | Lauren Silvernail | SEE REMARKS | -2.70K | $7.46 | -$20.13K | SELL | -2.89% | 90.69K | Jan 25 | View |
| Jan 26, 2021 | Michael M Jafar | SEE REMARKS | -2.70K | $7.46 | -$20.13K | SELL | -1.52% | 174.85K | Jan 25 | View |
| Jan 26, 2021 | Rui Avelar | SEE REMARKS | -2.70K | $7.46 | -$20.13K | SELL | -1.97% | 134.10K | Jan 25 | View |
| Jan 26, 2021 | David Moatazedi | SEE REMARKS | -8.31K | $7.46 | -$61.99K | SELL | -4.56% | 173.76K | Jan 25 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.